vs
Side-by-side financial comparison of INTERGROUP CORP (INTG) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.
INTERGROUP CORP is the larger business by last-quarter revenue ($17.3M vs $9.1M, roughly 1.9× Protalix BioTherapeutics, Inc.). INTERGROUP CORP runs the higher net margin — 8.8% vs -60.3%, a 69.1% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-481.0K). Over the past eight quarters, INTERGROUP CORP's revenue compounded faster (7.8% CAGR vs -6.7%).
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
INTG vs PLX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $9.1M |
| Net Profit | $1.5M | $-5.5M |
| Gross Margin | — | 49.4% |
| Operating Margin | 11.6% | -51.1% |
| Net Margin | 8.8% | -60.3% |
| Revenue YoY | 19.8% | -49.9% |
| Net Profit YoY | 155.6% | -184.8% |
| EPS (diluted) | $0.71 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.3M | $9.1M | ||
| Q3 25 | $17.9M | $17.9M | ||
| Q2 25 | $16.2M | $15.7M | ||
| Q1 25 | $16.8M | $10.1M | ||
| Q4 24 | $14.4M | $18.2M | ||
| Q3 24 | $16.9M | $18.0M | ||
| Q2 24 | $13.4M | $13.5M | ||
| Q1 24 | $14.9M | — |
| Q4 25 | $1.5M | $-5.5M | ||
| Q3 25 | $-535.0K | $2.4M | ||
| Q2 25 | $-2.2M | $164.0K | ||
| Q1 25 | $-578.0K | $-3.6M | ||
| Q4 24 | $-2.7M | $6.5M | ||
| Q3 24 | $-398.0K | $3.2M | ||
| Q2 24 | $-4.9M | $-2.2M | ||
| Q1 24 | $-3.2M | — |
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
| Q4 25 | 11.6% | -51.1% | ||
| Q3 25 | 15.3% | 11.9% | ||
| Q2 25 | 8.1% | 7.5% | ||
| Q1 25 | 14.0% | -41.0% | ||
| Q4 24 | 5.9% | 39.6% | ||
| Q3 24 | 18.5% | 22.2% | ||
| Q2 24 | 3.7% | -18.0% | ||
| Q1 24 | 4.8% | — |
| Q4 25 | 8.8% | -60.3% | ||
| Q3 25 | -3.0% | 13.2% | ||
| Q2 25 | -13.9% | 1.0% | ||
| Q1 25 | -3.4% | -35.8% | ||
| Q4 24 | -18.9% | 35.6% | ||
| Q3 24 | -2.4% | 18.0% | ||
| Q2 24 | -36.7% | -16.4% | ||
| Q1 24 | -21.3% | — |
| Q4 25 | $0.71 | $-0.06 | ||
| Q3 25 | $-0.25 | $0.03 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | $-0.27 | $-0.05 | ||
| Q4 24 | $-1.26 | $0.10 | ||
| Q3 24 | $-0.18 | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | $-1.44 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.5M | $14.7M |
| Total DebtLower is stronger | $233.2M | — |
| Stockholders' EquityBook value | $-85.2M | $48.2M |
| Total Assets | $101.1M | $82.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.5M | $14.7M | ||
| Q3 25 | $6.0M | $13.6M | ||
| Q2 25 | $6.1M | $17.9M | ||
| Q1 25 | $4.8M | $19.5M | ||
| Q4 24 | $15.4M | $19.8M | ||
| Q3 24 | $12.2M | $27.4M | ||
| Q2 24 | $11.6M | $23.4M | ||
| Q1 24 | $19.5M | — |
| Q4 25 | $233.2M | — | ||
| Q3 25 | $237.8M | — | ||
| Q2 25 | $240.5M | — | ||
| Q1 25 | $241.5M | — | ||
| Q4 24 | $227.2M | — | ||
| Q3 24 | $218.1M | — | ||
| Q2 24 | $225.7M | — | ||
| Q1 24 | $225.0M | — |
| Q4 25 | $-85.2M | $48.2M | ||
| Q3 25 | $-86.7M | $52.9M | ||
| Q2 25 | $-86.1M | $49.9M | ||
| Q1 25 | $-84.5M | $45.2M | ||
| Q4 24 | $-83.9M | $43.2M | ||
| Q3 24 | $-80.9M | $32.4M | ||
| Q2 24 | $-80.3M | $28.6M | ||
| Q1 24 | $-76.4M | — |
| Q4 25 | $101.1M | $82.3M | ||
| Q3 25 | $102.5M | $82.3M | ||
| Q2 25 | $104.1M | $78.5M | ||
| Q1 25 | $103.2M | $73.9M | ||
| Q4 24 | $110.6M | $73.4M | ||
| Q3 24 | $109.3M | $61.6M | ||
| Q2 24 | $107.8M | $91.5M | ||
| Q1 24 | $119.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-23.0K | $2.0M |
| Free Cash FlowOCF − Capex | $-481.0K | $1.6M |
| FCF MarginFCF / Revenue | -2.8% | 17.8% |
| Capex IntensityCapex / Revenue | 2.6% | 4.4% |
| Cash ConversionOCF / Net Profit | -0.02× | — |
| TTM Free Cash FlowTrailing 4 quarters | $739.0K | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-23.0K | $2.0M | ||
| Q3 25 | $-296.0K | $-3.7M | ||
| Q2 25 | $5.9M | $-5.2M | ||
| Q1 25 | $-854.0K | $-5.1M | ||
| Q4 24 | $-781.0K | $4.0M | ||
| Q3 24 | $3.4M | $4.1M | ||
| Q2 24 | $6.8M | $-3.6M | ||
| Q1 24 | $1.9M | — |
| Q4 25 | $-481.0K | $1.6M | ||
| Q3 25 | $-1.3M | $-4.2M | ||
| Q2 25 | $3.6M | $-5.7M | ||
| Q1 25 | $-1.2M | $-5.4M | ||
| Q4 24 | $-1.1M | $3.6M | ||
| Q3 24 | $3.1M | $4.0M | ||
| Q2 24 | $2.7M | $-3.8M | ||
| Q1 24 | $1.1M | — |
| Q4 25 | -2.8% | 17.8% | ||
| Q3 25 | -7.1% | -23.7% | ||
| Q2 25 | 22.5% | -36.2% | ||
| Q1 25 | -6.8% | -53.0% | ||
| Q4 24 | -7.8% | 19.6% | ||
| Q3 24 | 18.3% | 22.4% | ||
| Q2 24 | 20.4% | -28.1% | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 2.6% | 4.4% | ||
| Q3 25 | 5.4% | 2.8% | ||
| Q2 25 | 13.9% | 2.8% | ||
| Q1 25 | 1.8% | 3.0% | ||
| Q4 24 | 2.4% | 2.3% | ||
| Q3 24 | 1.6% | 0.5% | ||
| Q2 24 | 30.4% | 1.3% | ||
| Q1 24 | 4.9% | — |
| Q4 25 | -0.02× | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
